Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

TD Cowen has downgraded Merck (NYSE:MRK) to hold from buy, citing Keytruda's impending loss of market exclusivity, or LOE. The bank said it no longer sees "viable arguments" for outperformance in the ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...

4Q23 results included charges related to the Daiichi Sankyo collaboration .

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Here are seven attractively valued dividend stocks investors can bet on for the long term, according to Bank of America ...

Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines. Click for more on MRK Q4 earnings.

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...